Refractory Chronic Cough: Cases Where Its Truly Refractory to Even Our Neurogenic Treatments

Monday, October 19, 2026

9:30 AM - 10:30 AM PT

Location: 502A

Moderator(s)

VD

Vaninder Kaur Dhillon, MD

Associate Professor
Johns Hopkins University
Cabin John, MD, United States

Panelist(s)

Daniel S. Fink, MD

Associate Professor
University of Colorado
DENVER, Colorado, United States
Inna A. Husain, MD

Medical Director of Laryngology
Powers Health
Chicago, IL, United States
JS

Jane R. Salois, PhD

Assistant Professor
University of Montana
Missoula, Montana, United States

Disclosure(s):

Vaninder Kaur Dhillon, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Daniel S. Fink, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

This session revolves around cases of refractory chronic cough for which the treatment strategy/algorithm is exhausted. Treatments include neuromodulators, SLP involvement for cough suppression therapy and SLN block. When these treatment strategies are employed and are not successful, what are the next steps. This session explores this topic in more detail using a multidisciplinary panel of individuals reviewing cough in a larger perspective as well as from neurogenic etiology.

Learning Objectives:

Discuss the treatment paradigm as it stands currently for refractory chronic cough
List treatment options that may exist for providers who are unable to treat refractory chronic cough with the typical algorithm of medications, nerve blocks and behavioral therapy
Define the treatment strategies for refractory, refractory chronic cough.